AGP Executive Report
Last update: 11 hours agoHIV Prevention Access: Gilead and PAHO agreed to widen access to twice-yearly lenacapavir (Yeztugo) for HIV PrEP across all PAHO Member States in Latin America and the Caribbean, using PAHO’s regional purchasing system and creating a pathway for 14 countries including Paraguay. Health Workforce Update: Paraguay’s government reached a preliminary deal with the National Union of Physicians for a 2,000,000-guaraní salary increase for public-sector doctors, aimed at preventing a Sept. 21–22 strike pending union ratification. Snakebite Preparedness: PAHO marked International Snakebite Awareness Day by highlighting the scale of snakebite harm in the Americas and reporting technical missions in Paraguay and other countries to strengthen surveillance, diagnosis, treatment, and antivenom access. Bone Marrow Hope: A new donor registration drive in Asunción and Mariano Roque Alonso will collect buccal swabs at Shopping del Sol and Shopping Mariano on Sept. 19, aligned with World Marrow Donor Day. Community Health Missions: MedAdvance held its first international event in Paraguay (Sept. 3–5) with 121 participants from 15 countries, partnering with Centro Médico Bautista to train and mobilize global healthcare missionaries.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Pharmaceutical Executive Daily: FDA Approves Fayuvi]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/24990778-912932933-69ad66ff9a88b963b53a43ee2436f89da07d52ad-1280x720-100x56.jpeg)
![<![CDATA[Pharmaceutical Executive Daily: FDA Approves Fayuvi]]>](/images/news-fallback.svg)
